Correlation Between Protagonist Therapeutics and Verona Pharma
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Verona Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Verona Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Verona Pharma PLC, you can compare the effects of market volatilities on Protagonist Therapeutics and Verona Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Verona Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Verona Pharma.
Diversification Opportunities for Protagonist Therapeutics and Verona Pharma
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Protagonist and Verona is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Verona Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verona Pharma PLC and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Verona Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verona Pharma PLC has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Verona Pharma go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Verona Pharma
Given the investment horizon of 90 days Protagonist Therapeutics is expected to under-perform the Verona Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Protagonist Therapeutics is 1.87 times less risky than Verona Pharma. The stock trades about -0.14 of its potential returns per unit of risk. The Verona Pharma PLC is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 4,122 in Verona Pharma PLC on October 20, 2024 and sell it today you would earn a total of 1,067 from holding Verona Pharma PLC or generate 25.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagonist Therapeutics vs. Verona Pharma PLC
Performance |
| Timeline |
| Protagonist Therapeutics |
| Verona Pharma PLC |
Protagonist Therapeutics and Verona Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagonist Therapeutics and Verona Pharma
The main advantage of trading using opposite Protagonist Therapeutics and Verona Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Verona Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verona Pharma will offset losses from the drop in Verona Pharma's long position.| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
| Verona Pharma vs. Ventyx Biosciences | Verona Pharma vs. Ideaya Biosciences | Verona Pharma vs. Protagonist Therapeutics | Verona Pharma vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |